- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vir Biotechnology Inc (VIR)Vir Biotechnology Inc stock price live, this page displays NASDAQ VIR stock exchange data. View the VIR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vir Biotechnology Inc real time stock price chart below.
What Is the Vir Biotechnology Inc Stock Price Today?
The Vir Biotechnology Inc stock price today is 8.35.
What Is the Stock Symbol for Vir Biotechnology Inc?
The stock ticker symbol for Vir Biotechnology Inc is VIR.
Is VIR the Same as $VIR?
$VIR is a common way to refer to the Vir Biotechnology Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Vir Biotechnology Inc Trade On?
Vir Biotechnology Inc is listed and trades on the NASDAQ stock exchange.
Is Vir Biotechnology Inc a Good Stock to Buy?
Determining whether Vir Biotechnology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Vir Biotechnology Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VIR quote. (ISIN: US92764N1028)
What Is the Vir Biotechnology Inc Stock Price Today?
The Vir Biotechnology Inc stock price today is 8.35.
What Is the Stock Symbol for Vir Biotechnology Inc?
The stock ticker symbol for Vir Biotechnology Inc is VIR.
Is VIR the Same as $VIR?
$VIR is a common way to refer to the Vir Biotechnology Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Vir Biotechnology Inc Trade On?
Vir Biotechnology Inc is listed and trades on the NASDAQ stock exchange.
Is Vir Biotechnology Inc a Good Stock to Buy?
Determining whether Vir Biotechnology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Vir Biotechnology Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VIR quote. (ISIN: US92764N1028)
8.35
+0.38(+4.77%)
Closed
Pre Market
8.50+0.15(+1.80%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.90
8.52
52 wk Range
6.56
13.09
VIR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.908.52
52 wk Range
6.5613.09
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
UnlockEV/EBITDA
UnlockBeta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
UnlockEV/EBITDA
UnlockBeta
VIR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Price Target
29.50
Upside
+253.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
Vir Biotechnology Inc Company Profile
Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company’s preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.
Vir Biotechnology Inc SWOT Analysis
Financial Outlook | Delve into Vir's financial stability and growth potential, with analyst price targets ranging from $26 to $110, despite current negative EPS projections |
Market Opportunity | Analysts project potential peak annual revenue exceeding $10 billion for Vir's hepatitis programs, addressing significant unmet medical needs |
Strategic Realignment | Explore Vir's streamlined focus on viral hepatitis and T-cell engagers, including a strategic licensing deal with Sanofi for oncology targets |
Clinical Breakthroughs | Vir's HDV and HBV therapies show promising results in Phase 2 trials, with 100% virologic response rates for HDV combination treatment |
VIR Full Pro Research
Institutional-Grade Stock Analysis
Understand how VIR earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
Vir Biotechnology Inc Earnings Call Summary for Q3/2024
- Positive Phase 2 SOLSTICE data for chronic hepatitis delta therapy; FDA IND clearance and fast track designation received
- Exclusive worldwide license agreement with Sanofi for three clinical-stage masked T-cell engagers and PRO-XTEN platform
- Strategic restructuring with 25% workforce reduction to focus on core programs in hepatitis and T-cell engagers
- Clinical development of T-cell engagers for solid tumors ongoing; data readouts expected in H2 2025
- Company prioritizing hepatitis programs and T-cell engagers; additional clinical data anticipated in 2025-2026
Last Updated: 08/02/2024, 04:55 PM
Read Full TranscriptCompare VIR to Peers and Sector
Metrics to compare | VIR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVIRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.2x | −2.1x | −0.7x | |
PEG Ratio | −0.17 | −0.01 | 0.00 | |
Price / Book | 0.9x | 1.7x | 2.6x | |
Price / LTM Sales | 14.6x | 12.0x | 3.2x | |
Upside (Analyst Target) | 121.6% | 322.9% | 47.0% | |
Fair Value Upside | Unlock | 18.7% | 7.5% | Unlock |
Analysts' Recommendations
6 Buy
3 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 29.50
(+253.29% Upside)
People Also Watch
FAQ
What Is the Vir Biotech (VIR) Stock Price Today?
The Vir Biotech stock price today is 8.35
What Stock Exchange Does Vir Biotech Trade On?
Vir Biotech is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Vir Biotech?
The stock symbol for Vir Biotech is "VIR."
What Is the Vir Biotech Market Cap?
As of today, Vir Biotech market cap is 1.15B.
What is Vir Biotech Earnings Per Share?
The Vir Biotech EPS is -3.93.
What Is the Next Vir Biotech Earnings Date?
Vir Biotech will release its next earnings report on Feb 20, 2025.
From a Technical Analysis Perspective, Is VIR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.